CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria


  • Products Id :- GDHC0042CHR
  • |
  • Pages: 135
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Austria

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Austria". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Austria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Austria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Austria is one of the largest healthcare markets, with a strong focus on pharmaceutical R&D. The value of the Austrian pharmaceutical market declined from USD3.30 billion in 2010 to USD3.23 billion in 2016, at a negative compound annual growth rate (CAGR) of 0.33%. However, in terms of Euro, the market value increased from EUR2.48 billion in 2010 to EUR2.87 billion in 2017, at a CAGR of 2%. The decline in the market value in Euro terms was driven by the fluctuations in the exchange rate of the Euro versus the US dollar and increased consumption of generics. The Austrian medical device market was valued at USD1.63 billion in 2010 and increased to USD1.95 billion in 2017.The main segments were nephrology and urology devices, orthopedic devices, ophthalmic devices, cardiovascular devices, and in vitro diagnostics. The robust healthcare system, high focus on R&D and change in demographics are expected to drive the growth of the pharmaceutical market. However, generic substitution and shortage of specialized staff act as a major barrier for the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Austria, and includes-

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, Merck, Sanofi and Gerot Lannach) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Roche, DePuy and Sanochemia Pharmazeutika)

- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Austria

- Porter's five forces analysis for pharmaceutical and medical devices market of Austria

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Austrian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to-

- Develop business strategies by understanding the trends shaping and driving the Austrian healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in the Austrian healthcare market.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary

Overview of Pharmaceutical Market

Overview of Medical Device Market

Deals Analysis

Porter's Five Forces Model

Market Access

Country Healthcare Landscape

Opportunities and Challenges

Appendix

List of Figures

Figure 1: Pharmaceutical Market, Austria, Revenue, 2009-2016 8

Figure 2: Medical Device Market, Austria, Revenue, 2009-2016 8

Figure 3: Generics Market Share (by value), Austria, Sales (%), 2015 8

Figure 4: Number of Deals (2017-2018) 12

Figure 5: 2017-2018 Deal Overview By Region 12

Figure 6: Country Profile, Austria, 2017 14

Figure 7: Pharmaceutical Market, Austria, Revenue, 2010-2017 16

Figure 8: Pharmaceutical Market, Austria, Revenue Forecast, 2018-2022 16

Figure 9: Pharmaceutical Market, Austria, Pharmaceutical Exports 17

Figure 10: Pharmaceutical Market, Austria, Top Export Partners 17

Figure 11: Pharmaceutical Market, Austria, Pharmaceutical Imports 18

Figure 12: Pharmaceutical Market, Austria, Top Import Partners 18

Figure 13: Pharmaceutical Market, Austria, Supply Channels 19

Figure 14: Pharmaceutical Market, Austria, Sales of Patented Drug Products by Major Therapeutic Class, 2016 21

Figure 15: Pharmaceutical Market, Austria, Major Players 23

Figure 16: Medical Device Market, Austria, Revenue 40

Figure 17: Medical Device Market, Austria, Revenue Forecast 40

Figure 18: Medical Device Market, Austria, Revenue by Segment 41

Figure 19: Nephrology and Urology Devices Market, Austria, Revenue 42

Figure 20: Nephrology and Urology Devices Market, Austria, Market Share of Major Players 42

Figure 21: Orthopedic Devices Market, Austria, Revenue 43

Figure 22: Orthopedic Devices Market, Austria, Market Share of Major Players 43

Figure 23: Ophthalmic Devices Market, Austria, Revenue 44

Figure 24: Ophthalmic Devices Market, Austria, Market Share of Major Players 44

Figure 25: Cardiovascular Market, Austria, Revenue 45

Figure 26: Cardiovascular Market, Austria, Market Share of Major Players 45

Figure 27: InVitro Diagnostics Market, Austria, Revenue 46

Figure 28: InVitro Diagnostics Market, Austria, Market Share of Major Players 46

Figure 29: Medical Device Market, Austria, Revenue of Major Players 48

Figure 30: Deal Value and Deal Count, Pharmaceutical Market, Austria, 2017-2018 68

Figure 31: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Austria, 2017-2018 68

Figure 32: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Austria, 2017-2018 68

Figure 33: Top Five Therapy Area by Deal Value, Pharmaceutical Market, Austria, 2017-2018 69

Figure 34: Top Five Therapy Area by Deal number, Pharmaceutical Market, Austria, 2017-2018 69

Figure 35: M&A Deals by Therapy Area, Pharmaceutical Market, Austria, 2017-2018 (by value and by number) 69

Figure 36: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Austria, 2017-2018 (by value and by number) 69

Figure 37: Private Equity Deals by Therapy Area, Pharmaceutical Market, Austria, 2017-2018 (by value and by number) 69

Figure 38: Medical Device Market Deals, Austria, 2017-2018 (by deal value, USDm) 70

Figure 39: Medical Device Market Deals, Austria, 2017- 2018 (by deal count) 70

Figure 40: Medical Device Market Deals Share (by deal count), Austria, 2017-2018 70

Figure 41: Medical Device Market Deals Share (by deal value), Austria, 2017-2018 70

Figure 42: Top Therapy Area by Deal Value, Medical Device, Austria, 2017-2018 71

Figure 43: Top Therapy Area by Deal Number, Medical Device, Austria, 2017-2018 71

Figure 44: M&A Deals by Therapy Area, Medical Device, Austria, 2017-2018 (by value and by number) 71

Figure 45: Venture Financing Deals by Therapy Area, Medical Device, Austria, 2017-2018 (by value and by number) 71

Figure 46: Private Equity Deals by Therapy Area, Medical Device Austria, 2017-2018 (by value and by number) 71

Figure 47: Healthcare System, Austria 76

Figure 48: Drug Funding and Reimbursement Approval Process, Austria 78

Figure 49: Austrian Social Security System, Austria 80

Figure 50: Services of Social Health Insurance, Austria 81

Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health) 83

Figure 52: Pharmaceutical and Consumer Price Index 83

Figure 53: Federal Ministry of Health, Organization Chart, Austria 85

Figure 54: Centralized Procedure, 2017, Austria 88

Figure 55: Decentralized Procedure, 2017, Austria 89

Figure 56: Decentralized Procedure, 2017, Austria 89

Figure 57: Mutual Recognition Procedure, 2017, Austria 90

Figure 58: Conformity Assessment of Class I Medical Devices, EU, 2017 92

Figure 59: Conformity Assessment of Class IIa Medical Devices, EU, 2017 93

Figure 60: Conformity Assessment of Class IIb Medical Devices, EU, 2017 94

Figure 61: Conformity Assessment of Class III Medical Devices, EU, 2017 95

Figure 62: European Patent Approval Process, EU, 2017 99

Figure 63: Unitary Patent Approval Process, EU, 2017 100

Figure 64: Trademark Approval Process, Austria, 2018 101

Figure 65: Clinical Trial Process, Austria, 2017 102

Figure 66: Number of Hospitals, Austria, 2010-2017 109

Figure 67: Diagnostic Equipment, Austria, 2010-2017 109

Figure 68: Hospital Beds (per 1,000 population), Austria 110

Figure 69: Acute Care Hospital Beds (per 1,000 population), Austria 110

Figure 70: Psychiatric Hospital Beds (per 1,000 population), Austria 110

Figure 71: Life Expectancy, 2010-2017, Austria 111

Figure 72: Immunization Rate (%), 2010-2017, Austria 111

Figure 73: PM2.5 (?g per m3), Austria, 2010-2016 112

Figure 74: CO2 Emissions (million tons), Austria, 2010-2016 112

Figure 75: Physicians (per 1,000 population), Austria, 2010-2016 113

Figure 76: Nurses (per 1,000 population), Austria, 2010-2016 113

Figure 77: Dentists (per 1,000 population), Austria, 2010-2016 113

Figure 78: Pharmacists (per 1,000 population), Austria, 2010-2016 113

Figure79: Major Causes of Mortality (per 100,000 population), Austria, 2015 114

Figure 80: Major Causes of Male Mortality, Austria, 2015 114

Figure 81: Major Causes of Female Mortality, Austria, 2015 114

Figure 82: Disability-Adjusted Life Years by Major Disease ('000), Austria, 2016 114

Figure 83: Healthcare Expenditure as Percentage of GDP (%), Austria, 2010-2017 115

Figure 84: Public-Private Share (%), Austria, 2010-2016 115

Figure 85: Major Components of Healthcare Spending (%), Austria, 2016 116

Figure 86: Opportunities and Challenges, Austria 120

List of Tables

Table 1: Pharmaceutical Market, Austria, Sales of Patented Drug Products by Major Therapeutic Class (USDm), 2016 21

Table 2: Medical Device Market, Austria, Revenue by Segment 41

Table 3: Nephrology and Urology Devices Market, Austria, Revenue and Market Share of Major Players 42

Table 4: Orthopedic Market, Austria, Revenue and Market Share of Major Players 43

Table 5: Ophthalmic Devices Market, Austria, Revenue and Market Share of Major Players 44

Table 6: Cardiovascular Devices, Austria, Revenue and Market Share of Major Players 45

Table 7: InVitro Diagnostics Devices Market, Austria, Revenue and Market Share of Major Players 46

Table 8: Market Authorization Fees, 2017, Austria 87

Table 9: Patent Fees, 2017, Austria 98

Table 10: Criteria for New Pharmacy Establishment, Austria 104

Table 11: Label of a Pharmaceutical Product, Austria, 2017 106

Table 12: Trade Associations, Austria 117

Table 13: Trade Fairs, Austria 118

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 1995 INR 141605
Site License
USD 3990 INR 283210
Corporate User License
USD 5985 INR 424815

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com